Legal & General Group
ODT

Legal & General Group’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Legal & General Group’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,810
Closed -$9K – 3742
2021
Q1 		$9K Buy
2,810
+167
+6% +$3.16K ﹤0.01% 3419
2020
Q4 		$51K Hold
2,643
– – ﹤0.01% 2801
2020
Q3 		$35K Sell
2,643
-511
-16% -$14.5K ﹤0.01% 2803
2020
Q2 		$133K Buy
3,154
+605
+24% +$19.6K ﹤0.01% 2454
2020
Q1 		$71K Sell
2,549
-858
-25% -$25K ﹤0.01% 2501
2019
Q4 		$111K Buy
3,407
+448
+15% +$13.9K ﹤0.01% 2564
2019
Q3 		$77K Buy
2,959
+1,782
+151% +$59.6K ﹤0.01% 2608
2019
Q2 		$43K Hold
1,177
– – ﹤0.01% 2839
2019
Q1 		$26K Hold
1,177
– – ﹤0.01% 3002
2018
Q4 		$17K Hold
1,177
– – ﹤0.01% 3156
2018
Q3 		$23K Hold
1,177
– – ﹤0.01% 3159
2018
Q2 		$26K Hold
1,177
– – ﹤0.01% 3087
2018
Q1 		$25K Buy
+1,177
New +$27.8K ﹤0.01% 3059

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Legal & General Group's ODT Position: Q2 2021 in Review

Legal & General Group sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q2 2021, closing a stake of 2,810 shares — an estimated $9K sold.

Legal & General Group first reported a position in ODT in Q1 2018 and held it in 13 quarters. The position peaked at $133K in Q2 2020. 69 funds tracked by Wall St. Rank hold ODT as of Q2 2021.

  • Legal & General Group reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 2,810 Odonate Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $9K.
  • Legal & General Group first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2018 and held it in 13 quarters.
  • Legal & General Group's Odonate Therapeutics, Inc. Common Stock position peaked at $133K in Q2 2020.
  • 69 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.